Stay updated on Pembrolizumab + Poly-ICLC in MRP Colon Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Poly-ICLC in MRP Colon Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Poly-ICLC in MRP Colon Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision identifier advances from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-18T01:10:47.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T01:40:35.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error instead of the previous content, replacing the study details and navigation with an access-denied message. This indicates a site-level access restriction rather than updates to the trial information.
    Difference
    19%
    Check dated 2026-09-20T00:30:10.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    The page revision label changed from v3.6.5 to v3.6.6. This reflects a minor maintenance update to the page metadata and does not alter study details, eligibility, or results.
    Difference
    0.1%
    Check dated 2026-08-29T19:17:55.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.4 to v3.6.5, indicating a minor maintenance/update to the page. This change does not appear to modify study details or eligibility criteria.
    Difference
    0.1%
    Check dated 2026-08-15T23:19:27.000Z thumbnail image
  7. Check
    86 days ago
    Change Detected
    Summary
    The page’s revision label updated from v3.6.3 to v3.6.4, indicating a new version of the page metadata rather than a modification to the study details.
    Difference
    0.1%
    Check dated 2026-07-25T13:02:52.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Poly-ICLC in MRP Colon Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Poly-ICLC in MRP Colon Cancer Clinical Trial page.